Athira Pharma Stock (NASDAQ:ATHA), Trade Ideas

Athira Pharma

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.

Long Ideas

News

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

ATHA

CAUD

GSAT

The Dow Jones index closed lower by around 20 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

Small Cap

TCRX

The Dow Jones closed higher by around 10 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Around $10M Bet On This Real Estate Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

Biotech

Analyst Ratings

General

ALLO

IBRX

LGND

Shares of ImmunityBio (NASDAQ: IBRX) were down 55.1% on Thursday after management announced that FDA issued a complete response letter (&#34;CRL&#34;) to its biologics license application (&#34;BLA&#34;) seeking approval for the combination use of its lead pipeline candidate, Anktiva (N-803), in pa

FDA Rejects ImmunityBio&#39;s Bladder Cancer Therapy Filing

Athira Pharma Inc

Atha Energy Corp

ATHABASCA MINERALS INC by Athabasca Minerals Inc.

Athabasca Minerals Inc

ATHABASCA OIL CORP by Athabasca Oil Corp.

Athabasca Oil Corp

Goldman Sachs analyst Eric Sheridan maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and lowers the price target from $555 to $500.

Price Target

Goldman Sachs Maintains Buy on Meta Platforms, Lowers Price Target to $500

Buybacks

TAL Education's Board Of Directors Extend The Share Repurchase Program Launched In April 2021 By Another 12 Months

Goldman Sachs analyst Brooke Roach initiates coverage on Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) with a Sell rating and announces Price Target of $14.

Initiation

VSCO

Goldman Sachs Initiates Coverage On Victoria's Secret with Sell Rating, Announces Price Target of $14

Goldman Sachs analyst Brooke Roach upgrades TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) from Neutral to Buy and raises the price target from $100 to $110.

Upgrades

Goldman Sachs Upgrades TJX Companies to Buy, Raises Price Target to $110

TAL Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) reported quarterly adjusted earnings of $0.08 per share which beat the analyst consensus estimate of $0.02 by 300 percent. This is a 500 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $429.56 million which beat the analyst consensus estimate of $389.78 million by 10.21 percent. This is a 59.70 percent increase over sales of $268.99 million the same period last year.

Earnings

Earnings Beats

TAL Education Q4 Adj $0.08 Beats $0.02 Estimate, Sales $429.56M Beat $389.78M Estimate

Deutsche Bank analyst Scott Deuschle maintains Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) with a Hold and raises the price target from $467 to $487.

Deutsche Bank Maintains Hold on Lockheed Martin, Raises Price Target to $487

The number of Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) tokens being burnt has significantly decreased over the past week amid a parallel surge in SHIB prices by nearly 15% in the last seven days. 
What Happened: Shibburn, a social media handle on X that tracks the number of SHIB tokens being burnt, reported a 39.90% decline in the number of tokens burnt over the past week. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">HOURLY SHIB UPDATE<a href="https://twitter.com/search?q=%24SHIB&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SHIB</a> Price: $0.00002512 (1hr -0.19% ▼ &#x7C; 24hr -7.56% ▼ ) Market Cap: $14,784,402,651 (-7.62% ▼) Total Supply: 589,273,968,765,110 TOKENS BURNT Past 24Hrs: 22,346,657 (0% ▲) Past 7 Days: 428,035,239 (-39.92% ▼)
&mdash; Shibburn (@shibburn) <a href="https://twitter.com/shibburn/status/1783390532636496063?ref_src=twsrc%5Etfw">April 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Over the last 24 hours, 22,346,657 tokens were burned, showing no change from the previous period.
The meme cryptocurrency is currently trading at $0.00002512, marking a 15.01% surge over the past seven days.
The total supply of Shiba Inu tokens is currently at 589,273,968,765,110, with a market cap of $14,784,402,651.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38386424/shiba-inu-whale-accumulates-237b-shib-in-one-transaction-much-in-store-for-the-shib-army-v?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Shiba Inu Whale Accumulates 237B SHIB In One Transaction: &#8216;Much In Store For The SHIB Army,&#8217; Vows Lead Developer</a>
Why It Matters: The recent surge in Shiba Inu&#8217;s price comes amid a series of significant developments in the Shiba Inu community.
Just a day ago, a <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38386424/shiba-inu-whale-accumulates-237b-shib-in-one-transaction-much-in-store-for-the-shib-army-v">whale accumulated 237 billion SHIB tokens</a> in a single transaction, signaling confidence in the meme coin&#8217;s performance. This whale activity was accompanied by a 26% weekly surge in Shiba Inu&#8217;s price.
Earlier in the week, Shiba Inu also saw a <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38346682/shiba-inu-army-cheers-as-burn-rate-soars-172-price-rebounds">172% surge in its burn rate</a>, coinciding with a notable rebound in SHIB&#8217;s market price. This increase in token burn rate removed over 5 million SHIB tokens from circulation, sending them to a &#8220;dead&#8221; wallet where they can no longer be traded or accessed.
Price Action: Shiba Inu is currently trading at $0.00002512, reflecting a 7.90% decline in the last 24 hours. The coin has surged over 148% year-to-date. Meanwhile, its primary competitor, Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), is trading at $0.1513, with a 6.66% decline in the last 24 hours and a 68.98% increase year-to-date. 
Comparatively, the king of cryptocurrencies, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), is trading at $64,221.70, showing a 0.05% decline in the last 24 hours and a 45.39% increase year-to-date, according to data <a href="https://pro.benzinga.com/dashboard">from Benzinga Pro</a>.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38376705/doge-shiba-and-other-memecoins-fueling-mass-adoption-of-bases-l2-network-coinbase-e?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Dogecoin, Shiba Inu And Other Memecoins Fueling Mass Adoption Of Base&#8217;s L2 Network, Coinbase Exec Says: &#8216;They Are Going To Be One Of The Biggest Drivers&#8217;</a>
Image Via Shutterstock 
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Kaustubh Bagalkote</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/topic/kaustubh-bagalkote" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$SHIB

'Dogecoin Killer' Shiba Inu Burn Rate Drops Over Last 24 Hours, Mirrors Decline In Price

Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $2.01 by 1.49 percent. This is a 13.33 percent increase over earnings of $1.80 per share from the same period last year. The company reported quarterly sales of $598.800 million which beat the analyst consensus estimate of $595.118 million by 0.62 percent. This is a 5.76 percent increase over sales of $566.200 million the same period last year.

CHKP

Check Point Software Q1 2024 Adj EPS $2.04 Beats $2.01 Estimate, Sales $598.800M Beat $595.118M Estimate

Global Autos Analyst Tom Narayan expressed concerns over the decreasing prices of electric vehicles (EVs), which could potentially hinder profitability for automakers.
What Happened: Narayan, during CNBC&#8217;s &#8220;Last Call&#8221; on Wednesday, pointed out that the pricing for EVs seems to be on a downward trend. This could pose a significant challenge for automakers like Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) in achieving profitability in the EV sector. 
He stated, "If pricing keeps coming down it'll be tough to get there."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">"The issue here is pricing for EVs looks like it's only going to go lower," says <a href="https://twitter.com/rbccm?ref_src=twsrc%5Etfw">@rbccm</a> Global Autos Analyst Tom Narayan as EV profitability remains elusive for automakers like Ford. "If pricing keeps coming down it'll be tough to get there." <a href="https://twitter.com/search?q=%24F&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$F</a> <a href="https://twitter.com/search?q=%24GM&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$GM</a> <a href="https://twitter.com/search?q=%24STLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$STLA</a> <a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> <a href="https://t.co/ZHcDEI3cXE">pic.twitter.com/ZHcDEI3cXE</a>
&mdash; Last Call (@LastCallCNBC) <a href="https://twitter.com/LastCallCNBC/status/1783278927928029358?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38367087/tesla-q1-earnings-preview-is-ev-giant-no-longer-a-growth-stock-analysts-cautious-wa?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Q1 Earnings Preview: Is EV Giant No Longer A &#8216;Growth Stock?&#8217; Analysts Cautious, Want Answers About Robotaxis, Model 2</a>
Why It Matters: Narayan&#8217;s tweet comes in the wake of <a href="https://www.benzinga.com/news/24/04/38423295/ford-cfo-says-ev-price-cuts-bringing-down-revenue-faster-than-company-can-cut-costs-if-the-pricing-s">Ford&#8217;s CFO, John Lawler, expressing concerns</a> over the rapid decrease in revenue due to EV price cuts. Lawler emphasized the company&#8217;s commitment to cost-cutting in its EV segment to counter the losses.
Earlier, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) had also <a href="https://www.benzinga.com/markets/equities/24/04/38348232/tesla-aggressively-cuts-prices-ahead-of-q1-report-ev-maker-lowers-model-3-y-prices-in-china-by-u">announced significant price cuts</a> in all trim levels of its electric vehicles in China, following a round of price cuts in the U.S.
Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) CEO Carlos Tavares had previously <a href="https://www.benzinga.com/news/24/01/36705212/stellantis-ceo-cautions-against-cost-reductions-after-tesla-slashes-price-of-its-best-selling-suv-yo">cautioned against price reductions</a> that might risk profitability and potentially make car manufacturers acquisition targets.
Price Action: As of close on Wednesday, Ford shares closed at $13.26, Tesla at $160.55, and Stellantis at $24.95, according to<a href="https://pro.benzinga.com"> Benzinga Pro</a>.
Read Next: <a href="https://www.benzinga.com/markets/equities/24/04/38374423/elon-musk-reacts-as-ark-invest-analyst-says-its-going-to-be-very-hard-for-tesla-rivals-to-catch-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Reacts As ARK Invest Analyst Says &#8216;It&#8217;s Going To Be Very Hard&#8217; For Tesla Rivals &#8216;To Catch Up To &nbsp;Them&#8217; In Pricing: &#8216;Accurate&#8217;</a>
Image via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Analyst Color

Equities

Tech

STLA

TSLA

To Lower Or Not? EV Pricing Dilemma Hampers Ford's Profitability, Warns Analyst

Influential analyst Rich Greenfield expressed uncertainty about the monetization of AI chatbots, despite acknowledging Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) as a key player in the crowded AI space.
What Happened: During &#8220;Last Call&#8221; CNBC on Wednesday, Greenfield highlighted that Meta&#8217;s commitment to AI investments comes at a time when the space has become &#8220;crowded&#8221; with competition from ChatGPT by Microsoft and OpenAI, Google Gemini, Anthropic, Perplexity.AI and more. 
"There is no doubt that $META is going to be a major player. I think the challenge for investors is one, how big is this investment cycle, given the level of competition, " Greenfield said.
He highlighted that while Meta&#8217;s investments in their virtual reality unit Reality Labs and their collaboration with Ray-Ban on AR headsets have been huge, these were not as competitive as the AI space.
"It's not so clear right now,&#8221; Greenfield said.
&#8220;Yes, AI is making your recommendations better and AI is making the ads better, the content on Facebook and Instagram is going to be better. But how you actually monetize an AI chatbot&#8230;the use case and the monetization, isn&#8217;t clear. It&#8217;s really early days," Greenfield said, advising investors to learn more about the same.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">"This is a very crowded space. There's no doubt that <a href="https://twitter.com/search?q=%24META&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$META</a> is going to be a major player," says <a href="https://twitter.com/RichLightShed?ref_src=twsrc%5Etfw">@RichLightShed</a> on Meta's commitment to AI investments. "It's not so clear right now… how you actually monetize an AI chatbot. The use case and the monetization is not clear." <a href="https://t.co/Zo0Xn5DB1U">pic.twitter.com/Zo0Xn5DB1U</a>
&mdash; Last Call (@LastCallCNBC) <a href="https://twitter.com/LastCallCNBC/status/1783273225603965242?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/24/04/38345502/elon-musk-reacts-after-nvidia-stock-plunges-10-and-erases-212b-market-cap-rookie-numbers?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Reacts After Nvidia Stock Plunges 10% And Erases $212B Market Cap: &#8216;Rookie Numbers&#8217;</a>
Why It Matters: Meta&#8217;s focus on AI development has been evident, with CEO Mark Zuckerberg recently <a href="https://www.benzinga.com/markets/equities/24/04/38422805/mark-zuckerberg-shifts-metas-focus-to-ai-agents-over-chatbots-apple-to-pursue-similar-holy-grail">hinting at a shift from chatbots </a>to more advanced AI &#8216;agents&#8217; during the<a href="https://www.benzinga.com/news/earnings/24/04/38416273/meta-platforms-q1-earnings-highlights-facebook-owner-beats-estimates-but-guidance-higher-costs-ding"> company&#8217;s Q1 2024 earnings call</a>. These AI agents, as per Zuckerberg, would be capable of handling more complex tasks and goals, performing numerous queries to achieve the desired outcome.
Moreover, Zuckerberg revealed that over 50% of the content on Instagram and 30% of posts on Facebook are <a href="https://www.benzinga.com/news/24/04/38420928/meta-ceo-mark-zuckerberg-more-than-50-of-the-content-people-see-on-instagram-is-now-ai-recommended">now recommended by artificial intelligence</a>. This revelation came during Meta's first-quarter financial results announcement, where the company reported a 27% year-over-year increase in revenue, beating Street consensus estimates.
Price Action: Meta&#8217;s stock closed at $493.50 on Wednesday, marking a 15.57% decrease from its previous close. The company&#8217;s Q1 earnings per share stood at $4.710, surpassing the estimated $4.320.
Read Next: <a href="https://www.benzinga.com/news/24/04/38349837/elon-musk-agrees-every-american-household-will-have-a-1-000-per-month-home-robot-in-7-years-time?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Agrees Every American Household Will Have A $1,000-Per-Month Home Robot In 7 Years&#8217; Time</a>
Image Credits &#8211; Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Mark Zuckerberg's Big AI Dreams For Meta 'Not So Clear:' Analyst Questions Profitability Of AI Chatbots

Business&nbsp;Outlook
For the three months ended&nbsp;March 31, 2024, the Company expects its retail transaction volume to be around 3,100 units and wholesale transaction volume to be around 900 units. The Company estimates that its total revenues including retail vehicle sales revenue, wholesale vehicle sales revenue and value-add-services revenue to be within the range of&nbsp;RMB300 million&nbsp;to&nbsp;RMB320 million. The Company expects its&nbsp;gross profit&nbsp;margin to be greater than&nbsp;6.5%. These forecasts reflect the Company&#39;s current and preliminary views on the market and operational conditions, which are subject to changes.

Guidance

UXIN

Uxin Expects Q4 Revenue of RMB300M-RMB320M

Uxin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UXIN#NASDAQ">UXIN</a>) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.36) by 97.22 percent. The company reported $57.815 million in sales this quarter. This is a 15.25 percent decrease over sales of $68.216 million the same period last year.

Uxin Q3 2024 Adj EPS $(0.01) Beats $(0.36) Estimate, Sales $57.815M Down From $68.216M YoY

Sen. Ted Cruz (R-TX) on Wednesday <a href="https://www.benzinga.com/topic/congress-trades">disclosed a transaction</a> in investment bank Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), and this has raised some eyebrows.
What Happened: In a filing with the Senate, Cruz said his spouse sold Goldman shares on April 15 and the proceeds could be worth up to $500,000. Incidentally, the company reported its quarterly results on the same day. The sale was mentioned as part offloading of the position.
The filing was in line with the &#8220;Stock Trading on Congressional Knowledge Act,&#8221; which requires Congressmen to publicly file and disclose any financial transaction within 45 days of its occurrence.&nbsp;The values of trades are given in a range.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="347" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25033026/image-213-1024x347.png" alt="" class="wp-image-308074" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25033026/image-213-1024x347.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25033026/image-213-300x102.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25033026/image-213-768x261.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25033026/image-213-1536x521.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25033026/image-213.png 1872w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Incidentally, Cruz&#8217; wife Heidi Cruz has been with Goldman since 2005 and she is currently serving as Managing Director at the firm.
See Also: <a href="https://www.benzinga.com/money/best-bank-stocks">Best Bank Stocks Right Now</a>
Why It&#8217;s Important: Goldman is among the big banks, which reported stellar results for the first quarter. The stock rallied about 3% to $400.88 on the day of its earnings release (April 15) before pulling back about 1% in the very next session.
Since then, the stock has reversed course and ended Wednesday&#8217;s session at $423.04, down 0.23% from its previous close, according to<a href="https://benzinga.grsm.io/lxquj26b2sag"> Benzinga Pro data.</a>
The company reported first-quarter top- and bottom-line beats, thanks to strong trading and investment banking revenues. CNBC Mad Money host Jim Cramer <a href="https://www.benzinga.com/markets/equities/24/04/38290992/jim-cramer-says-he-likes-earnings-from-these-big-banks-so-much-heres-why">picked Goldman as one of the big bank </a>earnings he liked this season due to the strong fee income relative to net interest income.
Given details of the purchase of those shares aren&#8217;t readily available, it isn&#8217;t known whether the transaction netted the senator a profit.
When Cruz was panned for allegedly inciting the Jan. 6, 2021 insurrection, corporate America chose to distance itself from tainted politicians. Goldman was among them but it chose to stand by Cruz&#8217;s wife who was employed with them.
Read Next: <a href="https://www.benzinga.com/news/24/04/38185125/elon-musk-agrees-with-ted-cruz-on-putting-homeland-security-secretary-on-trial-the-precedent-is-crys">Elon Musk Agrees With Ted Cruz On Putting Homeland Security Secretary On Trial: &#8216;The Precedent Is Crystal Clear&#8217;</a>
Photo by Consolidated News Photos on Shutterstock

Government

Regulations

Politics

GOP Senator Ted Cruz Sold Shares Of This Big Bank On Q1 Earnings Release Date: Here Are The Details

Group Financial Targets and Outlook: 2024 &bull; Returns: targeting RoTE of greater than 10% and c.10.5% excluding inorganic activity &bull; Income: targeting Barclays Group NII excluding IB and Head Office of c.&pound;10.7bn, of which Barclays UK NII of c.&pound;6.1bn1 &bull; Costs: targeting Group cost: income ratio of c.63%, which includes c.&pound;1bn of gross efficiency savings in 2024 &bull; Impairment: expect an LLR of 50-60bps through the cycle &bull; Capital: expect to operate within the CET1 ratio target range of 13-14% 2026 &bull; Returns: targeting a greater than 12% RoTE &bull; Capital returns: plan to return at least &pound;10bn of capital to shareholders between 2024 and 2026, through dividends and share buybacks, with a continued preference for buybacks. Plan to keep total dividend stable at 2023 level in absolute terms, with progressive dividend per share growth driven through share count reduction as a result of increased share buybacks. Dividends will continue to be paid semi-annually. This multi-year plan is subject to supervisory and Board approval, anticipated financial performance and our published CET1 ratio target range of 13-14% &bull; Income: targeting Group total income of c.&pound;30bn &bull; Costs: targeting total Group operating expenses of c.&pound;17.0bn and a Group cost: income ratio of high 50s in percentage terms. This includes total gross efficiency savings of c.&pound;2bn by 2026 &bull; Impairment: expect an LLR of 50-60bps through the cycle &bull; Capital: expect to operate within the CET1 ratio target range of 13-14%&ndash; Targeting IB RWAs of c.50% of Group RWAs in 2026&ndash; Impact of regulatory change on RWAs in line with prior guidance, expected to be at lower end of 5&ndash;10% of Group RWAs. This includes c.&pound;16bn RWAs expected in H224 due to USCB moving to Internal Ratings-Based (IRB) models

Barclays Reiterated  2024 Outlook: Targets Barclays Group NII Excluding Barclays Investment Bank And Head Office Of £10.7B, Expects RoTE Of Greater Than 10% In 2024 And 10.5% Excluding Inorganic Activity

Unilever Continues To Expect FY24 Underlying Sales Growth To Be Within Its Multi-year Range Of 3% - 5%, With Increasing Contribution From Volume Growth

Unilever Q1 FY24 Sales €15.0B, Up 1.4% YoY, With Underlying Sales Growth Of 4.4%

Barclays (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCS#NYSE">BCS</a>) reported quarterly earnings of $0.52 per share which missed the analyst consensus estimate of $0.58 by 10.34 percent. The company reported $8.818 billion in sales this quarter. This is a 0.32 percent increase over sales of $8.790 billion the same period last year.

Earnings Misses

Barclays Q1 2024 GAAP EPS $0.52 Misses $0.58 Estimate, Sales $8.818B Up From $8.790B YoY

Mark Zuckerberg has outlined three strategies for Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) to monetize its <a href="https://www.benzinga.com/news/24/04/38400945/metas-massive-1b-bet-on-nvidia-h100-gpu-cluster-will-dwarf-every-other-companys-target-but-zuckerber">substantial investments</a> in artificial intelligence (AI.)
What Happened: Zuckerberg, during the <a href="https://www.benzinga.com/news/earnings/24/04/38416273/meta-platforms-q1-earnings-highlights-facebook-owner-beats-estimates-but-guidance-higher-costs-ding">March 2024 quarter earnings</a> call, expressed his confidence in Meta&#8217;s AI capabilities, particularly with the launch of Llama 3, the company&#8217;s latest AI model.
He stated that Meta will &#8220;invest significantly more over the coming years to build even more advanced models and the largest scale AI services in the world.&#8221;
Despite the substantial costs associated with this ambition, Meta plans to increase its capital expenditure for this year to $35 billion to $40 billion, primarily for AI investments. This announcement resulted in a 16% stock drop in after-hours trading.
See Also: <a href="https://www.benzinga.com/general/entertainment/24/04/38397316/elon-musk-says-morgan-freeman-is-awesome-after-american-actor-says-hes-a-huge-fan-of-tesla-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Says Morgan Freeman Is &#8216;Awesome&#8217; After American Actor Says He&#8217;s A Huge Fan Of Tesla CEO</a>
Zuckerberg, however, is confident that Meta&#8217;s AI investments will yield significant profits in the future. He outlined three specific ways in which AI could become a &#8220;massive business&#8221; for Meta.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
<h2 class="wp-block-heading">Zuckerberg's 3-Step Plan To Monetize AI Investments:</h2>
<h4 class="wp-block-heading">1. Charging Companies For Using Generative AI Tools</h4>
The first method involves companies paying Meta for generative AI tools, such as services supporting automated interactions with users and customers. This could become a reality within the next five years, according to Zuckerberg.
<h4 class="wp-block-heading">2. Advertisements</h4>
The second approach is to integrate ads or paid content into AI interactions. This aligns with Meta&#8217;s core business of selling digital advertising.
<h4 class="wp-block-heading">3. Monetizing Large AI Models</h4>
The third potential revenue stream is charging for access to Meta&#8217;s increasingly larger AI models.
Why It Matters: Zuckerberg&#8217;s announcement comes after Meta <a href="https://www.benzinga.com/news/24/04/38421280/metas-stock-plunge-after-q1-numbers-an-overreaction-to-zuckerbergs-capex-move-says-gene-munster-he-w">announced plans</a> to significantly increase its capital expenditure for AI investments.
This move has raised concerns among investors, given the company&#8217;s history of overspending on new technologies, such as the Metaverse.
These strategies align with Meta&#8217;s recent AI initiatives, including the launch of its latest AI model, <a href="https://www.benzinga.com/news/24/04/38330339/mark-zuckerbergs-meta-says-llama-3-beats-googles-gemini-mistral-and-jeff-bezos-backed-anthropics-cla">Llama 3</a>, which has outperformed other AI models in benchmark tests.
Price Action: Meta stock closed 0.52% lower at $493.50 on Wednesday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next: <a href="https://www.benzinga.com/news/24/04/38420928/meta-ceo-mark-zuckerberg-more-than-50-of-the-content-people-see-on-instagram-is-now-ai-recommended">Meta CEO Mark Zuckerberg: &#8216;More Than 50% Of The Content People See On Instagram Is Now AI Recommended&#8217;</a>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Mark Zuckerberg Photo by Alexandros Michailidis on Shutterstock

Mark Zuckerberg Lays Down How Meta Will Make Money From Its Multi-Billion Dollar AI Bet

Subsea 7 (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SUBCY#OTC">SUBCY</a>) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.03) by 400 percent. The company reported quarterly sales of $1.395 billion which missed the analyst consensus estimate of $1.492 billion by 6.53 percent. This is a 11.96 percent increase over sales of $1.246 billion the same period last year.

SUBCY

Subsea 7 Q1 2024 GAAP EPS $0.09 Beats $(0.03) Estimate, Sales $1.395B Miss $1.492B Estimate

Pershing Square founder Bill Ackman has in the past made <a href="https://www.benzinga.com/news/23/09/34429616/bill-ackman-calls-for-strong-alternatives-to-very-beatable-biden-and-trump-but-tells-why-he-wont-run">no bones about his displeasure</a> about President Joe Biden&#8217;s handling of his job and on Wednesday, he categorically ruled out voting for the incumbent.
Biden Or Trump: &#8220;For anyone who is still confused on the topic, I am not voting for Biden,&#8221; he said in a post on X, formerly Twitter. When a conservative journalist prodded him as to whether he would vote for probable Republican nominee Donald Trump, he did not rule out the possibility.
&#8220;And yes, I am open to voting for [Donald Trump],&#8221; Ackman said. But he hinted that he could make his final choice closer to the election date. &#8220;I will share whom I am supporting when I make my decision closer to the election. I like to preserve optionality,&#8221; he said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">For anyone who is still confused on the topic, I am not voting for Biden.
&mdash; Bill Ackman (@BillAckman) <a href="https://twitter.com/BillAckman/status/1783294245215908143?ref_src=twsrc%5Etfw">April 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In a separate thread, replying to a social-media user&#8217;s question as to whether he has ever voted for a Republican, Ackman said he voted for Trump in 2016.
See Also: <a href="https://www.benzinga.com/money/how-to-invest-in-startups">How To Invest In Startups</a>
Hostage Issue: Separately, Ackman responded to a post regarding the White House&#8217;s briefing on Biden signing the Ukraine and Israeli aid bill into law. The hedge-fund manager slammed the president for not acting decisively on the hostages being held in Gaza.
&#8220;I have not heard @potus Biden take ownership of this issue,&#8221; Ackman said.
&#8220;I have heard him talk about calls for a ceasefire, shrinkflation, hotel fees, and four more years, but not the fact that hostages including American hostages are still being held in Gaza.&#8221;
This is evident from the president&#8217;s delegation to staff and what he speaks to the American public, Ackman said. &#8220;He has not made clear that returning the hostages is high on his priority list. He is too focused on other talking points in an attempt to get re-elected. And the media are letting him off the hook on this issue,&#8221; he added.
The hostage issue came to the centerstage on Wednesday after Hamas released a <a href="https://www.nytimes.com/live/2024/04/24/world/israel-gaza-war-hamas">video</a> of Israeli-American  Hersh Goldberg-Polin, who was taken captive during the Oct. 7 Hamas strikes against Israel. 
Ackman has in the past expressed hopes that<a href="https://www.benzinga.com/news/23/03/31469332/not-biden-bill-ackman-says-this-corporate-ceo-more-likely-to-win-against-trump-in-presidential-race"> JPMorgan CEO Jamie Dimon would throw in his hat in the ring </a>and contest in the Democratic primary. He previously approved of businessman Vivek Ramaswamy, who has since then dropped off the race. The fund manager was also found backing Democrat turned-independent candidate Robert Kennedy Jr.&#8217;s stance on the COVID-19 vaccine. In January, he denoted $1 million to support Rep. Dean Phillips (D-Minn.) to become the Democratic nominee in the 2024 presidential election. Phillips quit the race in early March.
Read Next: <a href="https://www.benzinga.com/news/24/02/37253969/bill-ackman-reveals-first-investment-book-he-read-was-the-same-one-that-influenced-warren-buffett-it">Bill Ackman Reveals First Investment Book He Read Was The Same One That Influenced Warren Buffett: &#8216;It Was Kind Of The Inspiration For My Career…&#8217;</a>
Trump vs Biden illustration was generated using artificial intelligence via MidJourney.

Media

Bill Ackman Says 'Not Voting For Biden,' Slams President For Inaction On American Hostage Issue: 'Too Focused On Other Talking Points…To Get Re-elected'

Athira Pharma GAAP EPS of -$3.09 beats by $0.25

Goldman Sachs analyst Corinne Johnson maintained a Hold rating on Athira Pharma (ATHA – Research Report) today. The company's shares closed today a...

Goldman Sachs Sticks to Their Hold Rating for Athira Pharma (ATHA)

JMP Securities analyst Jason Butler reiterated a Buy rating on Athira Pharma (ATHA – Research Report) today and set a price target of $19.00. Jason...

Favorable Outlook for Athira Pharma with Strong Trial Progress and Robust Financials Prompting a 'Buy' Rating

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Athira Pharma (ATHA – Research Report), BeiGene (BGN...

Analysts Are Bullish on These Healthcare Stocks: Athira Pharma (ATHA), BeiGene (BGNE)

Tracking Baker Brothers Portfolio - Q4 2023 Update

A rating of 83 puts Athira Pharma Inc (ATHA) near the top of the Biotechnology industry according to InvestorsObserver. Athira Pharma Inc's score of 83 means it scores higher than 83% of stocks in the industry. Athira Pharma Inc also received an overall rating of 71, putting it above 71% of all stocks. Biotechnology is ran

Is Athira Pharma Inc (ATHA) a Good Buy in the Biotechnology Industry?

A rating of 74 puts Athira Pharma Inc (ATHA) near the top of the Healthcare sector according to InvestorsObserver.Athira Pharma Inc's score of 74 means that it ranks higher than 74% of stocks in the sector. In addition, its overall score of 41 ranks it higher than 41% of all stocks. ATHA has an Overall Score of 41. Find ou

Will Athira Pharma Inc (ATHA) Stay at the Top of the Healthcare Sector?

The market has been down on Athira Pharma Inc (ATHA)  stock recently. ATHA gets a Bearish score from InvestorsObserver Stock Sentiment Indicator. Athira Pharma Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ATHA!See Full ATHA ReportWhat is Stock Sentiment?In invest

Is it Time to Dump Athira Pharma Inc (ATHA) Stock After it Has Fallen 12.98% in a Week?

Athira Pharma Inc (ATHA) is near the middle in its industry group according to InvestorsObserver. ATHA gets an overall rating of 54. That means it scores higher than 54 percent of stocks. Athira Pharma Inc gets a 59 rank in the Biotechnology industry. Biotechnology is number 20 out of 148 industries. ATHA has an Overall Sc

Is Athira Pharma Inc (ATHA) Stock at the Top of the Biotechnology Industry?

ANGI, MLKN and KOD are among after hour movers

ABBV

ABCL

ACAD

ACHL

ADAP

AKRO

ALGS

ANGI

ARGX

AVTE

BCRX

BCYC

BGNE

BMEA

BMRN

CABA

CALA

CERS

CYTK

DNLI

GLUE

HOOK

HRTX

IMCR

IMTX

INCY

INZY

KYMR

LENZ

MDGL

MLKN

NAMSW

NRIX

PHAT

RARE

REPL

ROIV

RVMD

RYTM

SGMT

TRDA

TSVT

XERS

ZYME

Press Releases

Athira Pharma to Participate in Sidoti December Small Cap Investor Conference

Health Care

Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies

Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease

Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update

Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer's and Parkinson's Diseases at AD/PD™ 2024 International Conference

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting

Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease